Alzheimer's Drugs Market Industry - Global Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
Alzheimer’s disease is a neurological disorder of the brain which is progressive and ultimately leads to loss of neurons. This condition leads to loss of memory and reasoning abilities. Currently, there is no treatment for Alzheimer’s, although there are certain ways of slowing down its progression. Physicians generally prescribe neurotransmitters like cholinesterase inhibitors, memantine, etc. to slow down the advancement of disease and improve some symptoms such as insomnia, depression, anxiety and agitation.
View full press release